Insight into anti-diabetic effect of low dose of stevioside

Biomedicine and Pharmacotherapy

Volumn 90, Issue , 2017, Pages 216-221

  Ilić, Vladimirka ^a   Vukmirović, Saša ^a   Stilinović, Nebojša ^a   Čapo, Ivan ^a   Arsenović, Milan ^a   Milijašević, Boris ^a  

^a UNIVERSITY OF NOVI SAD   (Serbia)

Author keywords

Diabetes mellitus; Stevia rebaudiana; Stevioside

Indexed keywords

EPINEPHRINE; SODIUM CHLORIDE; STEVIOSIDE; ALLOXAN; ANTIDIABETIC AGENT; GLUCOSIDE; INSULIN; KAURANE DERIVATIVE; PLANT EXTRACT;

ALLOXAN-INDUCED DIABETES MELLITUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; AQUEOUS SOLUTION; ARTICLE; CONTROLLED STUDY; DRUG DOSE REGIMEN; EXPERIMENTAL HYPERGLYCEMIA; GLUCOSE BLOOD LEVEL; LOW DRUG DOSE; MOUSE; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; ANIMAL; BLOOD; CHEMICALLY INDUCED; CHEMISTRY; DRUG EFFECTS; EXPERIMENTAL DIABETES MELLITUS; GLUCOSE TOLERANCE TEST; HYPERGLYCEMIA; MALE; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYTOTHERAPY; PROCEDURES; STEVIA;

ALLOXAN; ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DITERPENES, KAURANE; GLUCOSE TOLERANCE TEST; GLUCOSIDES; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MICE; PHYTOTHERAPY; PLANT EXTRACTS; STEVIA;

EID: 85016331795     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2017.03.045     Document Type: Article

References (30)

1. [1] Madan, S., Sayeed, A., Singh, G.N., Kohli, K., Kumar, Y., Singh, R., Garg, M., Stevia rebaudiana (Bert.) Bertoni —a review. Indian J. Nat. Prod. Resour. 1:3 (2010), 267–286.
2. [2] Chatsudthipong, V., Muanprasat, C., Therapeutic benefits beyond sweetness. Pharmacol. Ther. 121:1 (2009), 41–54.
3. [3] Geuns, J.M., Stevioside. Phytochemistry 64:5 (2003), 913–921.
4. [4] Shankar, P., Ahuja, S., Sriram, K., Non-nutritive sweeteners: review and update. Nutrition 29:11–12 (2013), 1293–1299.
5. [5] Roberts, C.K., Sindhu, K.K., Oxidative stress and metabolic syndrome. Life Sci. 84 (2009), 705–712.
6. [6] Bonomini, F., Rodella, L.F., Rezzani, R., Metabolic syndrome, aging and involvement of oxidative stress. Aging Dis. 6:2 (2015), 109–120.
7. [7] International Diabetes Federation, Diabetes Atlas (2015), Seventh Edition. http://www.diabetesatlas.org/ (Accessed 04.10.2016.).
8. [8] Basak, S.S., Candan, F., Effect of Laurus nobilis L. esential oil and its main components of α-glucosidase and reactive oxygen species scavenging activity. Iran J. Pharm. Res. 12:2 (2013), 367–379.
9. [9] Chan, P., Tomlinson, B., Chen, Y.J., Liu, J.C., Hsieh, M.H., Cheng, J.T., A double-blind placebo-controlled study of the effectiveness and tolerability of oral stevioside in human hypertension. Br. J. Clin. Pharmacol. 50:3 (2000), 215–220.
10. [10] EFSA ANS Panel (EFSA Panel on Food Additives and Nutrient Sources added to food), Scientific opinion on the safety of the proposed amendment of the specifications for steviol glycosides (E 960) as a food additive. EFSA J., 13(12), 2015, 4316.
11. [11] Center for Drug Evaluation and Research (CDER) at the Food and Drug Administration (FDA). Guidance for Industry – Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers. 2005.
12. [12] Sabo, A., Stilinovic, N., Vukmirovic, S., Bukumiric, Z., Capo, I., Jakovljevic, V., Pharmacodynamic action of a commercial preparation of the mushroom Coprinus comatus in rats. Phytother. Res. 24:10 (2010), 1532–1537.
13. [13] Williams, M.A., Quantitative methods in biology. Glauert, A.M., (eds.) Practical Methods in Electron Microscopy, 1977, North-Holland, Amsterdam, 48–62.
14. [14] Shivanna, N., Naika, M., Khanum, F., Kaul, V.K., Antioxidant, anti-diabetic and renal protective properties of Stevia rebaudiana. J. Diabetes Complicat. 27:2 (2013), 103–113.
15. [15] Badawi, A.M., El-tablawy, N.A.-, Bassily, N.S., El-Behairy, S.A., Stevioside is a low caloric sweetner to milky drink and its protective role against oxidative stress in diabetic rats. Egypt. J. Hosp. Med. 20 (2005), 163–176.
16. [16] Jeppesen, P.B., Gregersen, S., Rolfsen, S.E., Jepsen, M., Colombo, M., Agger, A., et al. Antihyperglycemic and blood pressure-reducing effects of stevioside in the diabetic Goto-Kakizaki rat. Metabolism 52:3 (2003), 372–378.
17. [17] Vasović, V., Rašković, A., Mikov, M., Mikov, I., Milijašević, B., Vukmirović, S., Budakov, Z., Effect of aqueous solution of stevioside on pharmacological properties of some cardioactive drugs. Vojnosanit. Pregl. 71:7 (2014), 667–672.
18. [18] Yusukawa, K., Kitanaka, S., Seo, S., Inhibitory effect of stevioside on tumor promotion by 12-O-tetradecanoylphorbol-13-acetate in two-stage carcinogenesis in mouse skin. Biol. Pharm. Bull. 25:11 (2002), 1488–1490.
19. [19] Mishra, S., Shamim, A., Stevia rebaudiana Bertoni: a review. Global J. Pharm. Res. 1:4 (2012), 689–692.
20. [20] Kujur, R.S., Singh, V., Ram, M., Yadava, H.N., Singh, K.K., Kumari, S., Roy, B., Antidiabetic activity and phytochemical screening of crude extract of Stevia rebaudiana in alloxan-induced diabetic rats. Pharmacogn. Res. 2:4 (2010), 258–263.
21. [21] Cekić, V., Vasović, V., Jakovljević, V., Mikov, M., Sabo, A., Hypoglycemic action of stevioside and a barley and brewers yeast based preparation in the experimental model on mice. Bosn. J. Basic Med. Sci. 11:1 (2011), 11–16.
22. [22] Rizzo, B., Zambonin, L., Angeloni, C., Leoncini, E., Dalla Sega, F.V., Prata, C., Fiorentini, D., Hrelia, S., Steviol glycosides modulate glucose transport in different cell types. Oxid. Med. Cell. Longev., 2013, 2013, 348169.
23. [23] Sharma, R., Yadav, R., Manivannan, E., Study of effect of Stevia rebaudiana bertoni on oxidative stress in type 3 diabetic rat models. Biomed. Aging Pathol. 2 (2012), 126–131.
24. [24] Misra, H., Soni, M., Silawat, N., Mehta, B.K., Jain, D.C., Antidiabetic activity of medium-polar extract from the leaves of Stevia rebaudiana Bert. (Bertoni) an alloxan-induced diabetic rats. J. Pharm. Bioallied Sci. 3:2 (2011), 242–248.
25. [25] Rašković, A., Jakovljević, V., Mikov, M., Farmakološki efekti komercijalnih preparata, Stevia rebaudiana–Bertoni. Iugosl. Physiol. Pharmacol. Acta 39:2 (2003), 75–86.
26. [26] Jeppesen, P.B., Rolfsen, S.E., Agger, A., Gregersen, S., Colombo, M., Xiao, J., et al. Can stevioside in combination with a soy-based dietary supplement be a new useful treatment of type 2 diabetes? An in vivo study in the diabetic Goto-Kakizaki rat. Rev. Diabet. Stud. 3:4 (2006), 189–199.
27. [27] Anton, S.D., Martin, C.K., Han, H., Coulon, S., Cefalu, W.T., Geiselman, P., Williamson, D.A., Effects of stevia, aspartame, and sucrose on food intake satiety, and postprandial glucose and insulin levels. Appetite 55 (2010), 37–43.
28. [28] Jeppesen, P.B., Gregersen, S., Poulsen, C.R., Hermansen, K., Stevioside acts directly on pancreatic β cells to secrete insulin: actions independent of cyclic adenosine monophosphate and adenosine triphosphate-sensitive K+-channel activity. Metabolism 149:2 (2000), 208–214.
29. [29] Lenzen, S., The mechanisms of alloxan- and streptozotocin-induced diabetes. Diabetologia 51 (2008), 216–226.
30. [30] Geeraert, B., Crombe, F., Hulsmans, M., Benhabile's, N., Geuns, J.M., Holvoet, P., Stevioside inhibits atherosclerosis by improving insulin signaling and antioxidant defense in obese insulin-resistant mice. Int. J. Obes. 34 (2010), 569–577.